Drawing for VIFOR PHARMA

USPTO serial 79058308

VIFOR PHARMA

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
TWOHIG, SHANNON MARIE
Law office
TMO LAW OFFICE 121

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 604: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with VIFOR PHARMA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
003Soaps, perfumery, essential oils, cosmetics, hair lotions; dentifricesABANDONED—
005Pharmaceutical and veterinary preparations for the treatment of immunologic diseases, namely, auto immune diseases; pharmaceuticals for the treatment of acute or chronic conditions or consequences of or associated with acute or chronic renal disease, namely, acute renal insufficiency, intrinsic kidney disease, glomerulonephritis, tubular disorders, and tubulointerstitial diseases, vasculitis of the kidney, vascular injury to the kidney, infection related kidney disorders, kidney neoplasms, congenital and genetic disorders, cystic disorders of the kidney, systemic diseases effecting the kidney, drugs, contrast agents, and toxin damage to the kidney; pharmaceutical preparations for dialysis and conditions associated with dialysis; pharmaceutical preparations for transplantation and transplant related conditions affecting the kidney; preparations used to treat patients suffering from iron deficiency anemia; sanitary preparations for medical purposes, namely, parapharmaceutical products in the nature of surgical dressings and wound dressings; dietetic foods adapted for medical use, food for babies; medical plasters, materials for dressings, namely, surgical dressings and wound dressings; material for stopping teeth, dental wax; all purpose disinfectantsABANDONED—
035Import agency services in the field of medicines and pharmaceutical preparations; retail stores featuring pharmaceuticals and parapharmaceutical and healthcare products, namely, preparations for the treatment of immunologic diseases, pharmaceuticals for the treatment of acute or chronic conditions or consequences of or associated with acute or chronic renal disease, pharmaceutical preparations for dialysis and conditions associated with dialysis, preparations for transplantation and transplant related conditions affecting the kidney, preparations used to treat patients suffering from iron deficiency anemia, parapharmaceutical preparations in the nature of surgical dressings and wound dressings, dietetic foods adapted for medical use, food for babies, medical plasters, material for stopping teeth, dental wax, and all purpose disinfectants; arranging for storage, transportation, and delivery of packages, namely, medicaments, pharmaceutical products, parapharmaceutical products, and products for healthcare via ground and air carriers; import-export agency services in the field of medicines, pharmaceutical, and sanitary preparations; education leadership development in the field of pharmacy and healthcareABANDONED—
039Transport and warehousing services, namely, transport, storage, and delivery and packaging of goods, namely, medicines, pharmaceutical, parapharmaceutical, healthcare, and sanitary preparationsABANDONED—
041Providing of training, namely, training sessions in the fields of pharmacy, healthcare, and sanitary practices and productsABANDONED—
042Scientific research and development in the field of medicines, pharmaceutical preparations, and pharmaceutical, parapharmaceutical, healthcare, and sanitary care productsABANDONED—
045Legal services and legal representation of third parties to the authorities and administration, namely, for the purposes of approval of pharmaceuticals and parapharmaceuticalsABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 30, 2021NREPNEW REPRESENTATIVE AT IB RECEIVED—
Sep 13, 2018RNWLINTERNATIONAL REGISTRATION RENEWED—
Oct 5, 2017CHLDCHANGE OF OWNER RECEIVED FROM IB—
Feb 17, 2017FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jul 30, 2011FINTFINAL DECISION TRANSACTION PROCESSED BY IB—
Jul 13, 2011FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jul 13, 2011FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jul 13, 2010MAB4ABANDONMENT NOTICE MAILED - INTER PARTES DECISION—
Jul 13, 2010ABN4ABANDONMENT - AFTER INTER PARTES DECISION—
Jul 13, 2010OP.TOPPOSITION TERMINATED NO. 999999—
Jul 13, 2010OP.SOPPOSITION SUSTAINED NO. 999999—
Jul 7, 2010OP.TOPPOSITION TERMINATED NO. 999999—
Jul 7, 2010OP.SOPPOSITION SUSTAINED NO. 999999—
Mar 19, 2010RFNPREFUSAL PROCESSED BY IB—
Feb 27, 2010OP.IOPPOSITION INSTITUTED NO. 999999—
Feb 26, 2010OPNSOPPOSITION NOTICE (IB REFUSAL) SENT TO IB—
Feb 26, 2010OPNCOPPOSITION NOTICE (IB REFUSAL) CREATED—
Feb 3, 2010ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 3, 2010REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jan 22, 2010RFNPREFUSAL PROCESSED BY IB—
Dec 24, 2009OP.IOPPOSITION INSTITUTED NO. 999999—
Dec 24, 2009OPNSOPPOSITION NOTICE (IB REFUSAL) SENT TO IB—
Dec 24, 2009OPNCOPPOSITION NOTICE (IB REFUSAL) CREATED—
Sep 1, 2009ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Sep 1, 2009PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 12, 2009NPUBNOTICE OF PUBLICATION—
Jul 29, 2009PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jul 29, 2009ALIEASSIGNED TO LIE—
Jul 20, 2009CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 13, 2009CNEAEXAMINERS AMENDMENT MAILED—
Jul 13, 2009XAECEXAMINER'S AMENDMENT ENTERED—
Jul 13, 2009CNEAEXAMINERS AMENDMENT -WRITTEN—
Apr 10, 2009CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 10, 2009CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 7, 2009TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 6, 2009CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 6, 2009ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Mar 24, 2009CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Mar 24, 2009CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Mar 16, 2009TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 16, 2009CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 16, 2009TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 7, 2008RFNTREFUSAL PROCESSED BY IB—
Oct 8, 2008RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Oct 8, 2008RFRRREFUSAL PROCESSED BY MPU—
Oct 8, 2008RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Oct 7, 2008CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 3, 2008DOCKASSIGNED TO EXAMINER—
Oct 3, 2008NWAPNEW APPLICATION ENTERED—
Oct 2, 2008REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance